Psychometric development of the Retinopathy Treatment Satisfaction Questionnaire (RetTSQ). [Retinopathy : Treatment Satisfaction]
Psychology, Health & Medicine, 14 (6), 740-754.
Comments on Speight et al.’s ‘Not all roads lead to Rome – a review of quality of life measurement in adults with diabetes’. [Diabetes : Quality of Life]
Diabetic Medicine 26 (10) 1076-1077.
Design of a measure of satisfaction with treatment for Macular Degeneration (MacTSQ) [Macular Disease : Treatment Satisfaction]
2007 International Society for Quality of Life Research meeting abstracts. The QLR Journal, A-120, Abstract #1150.
Retinopathy Treatment Satisfaction Questionnaire (RetTSQ): psychometric development. [Retinopathy : Quality of Life]
2007 International Society for Quality of Life Research meeting abstracts. The QLR Journal, A-21, Abstract #1197.
Retinopathy-Dependent Quality of Life Questionnaire (RetDQoL): psychometric development. [Retinopathy : Quality of Life]
2007 International Society for Quality of Life Research meeting abstracts. The QLR Journal, A-60, Abstract #1198.
The MacDQoL individualised measure of the impact of macular degeneration on quality of life: reliability and responsiveness. [Macular Disease : Quality of Life]
American Journal of Ophthalmology 146 (3) 447-454. View article here.
Measuring quality of life in macular degeneration. [Macular Disease : Quality of Life]
In VA Preedy (Ed) Handbook of disease burdens and quality of life measures. Heidelberg: Springer-Vorlag (in press).
The MacDQoL individualized measure of the impact of macular disease on quality of life. [Macular Disease : Quality of Life]
Evaluating patients’ satisfaction with eye clinic services. [Macular Disease : Clinic/Service Satisfaction]
Digest, Journal of the Macular Disease Society, 20-21.
Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomized controlled trial. [Diabetes : Treatment Satisfaction]
The Lancet, 371 (9618), 1073-1084. View article here.
